Clinical Research Center Thrombosis, Haemostasis and Vascular Biology Research Group of the Hungarian Academy of Sciences, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary.
J Thromb Haemost. 2011 Jan;9(1):9-20. doi: 10.1111/j.1538-7836.2010.04070.x.
Factor (F)XIII is a protransglutaminase that, in addition to maintaining hemostasis, has multiple plasmatic and intracellular functions. Its plasmatic form (pFXIII) is a tetramer of two potentially active A (FXIII-A) and two inhibitory/carrier B (FXIII-B) subunits, whereas its cellular form (cFXIII) is a dimer of FXIII-A. FXIII-A belongs to the family of transglutaminases (TGs), which show modest similarity in the primary structure, but a high degree of conservatism in their domain and sub-domain secondary structure. FXIII-A consists of an activation peptide, a β-sandwich, a catalytic and two β-barrel domains. FXIII-B is a glycoprotein consisting of 10 repetitive sushi domains each held together by two internal disulfide bonds. The structural elements of FXIII-A involved in the interaction with FXIII-B have not been elucidated; in FXIII-B the first sushi domain seems important for complex formation. In the circulation pFXIII is bound to the fibrinogen γ'-chain through its B subunit. In the process of pFXIII activation first thrombin cleaves off the activation peptide from FXIII-A, then in the presence of Ca(2+) FXIII-B dissociates and FXIII-A becomes transformed into an active transglutaminase (FXIIIa). The activation is highly accelerated by the presence of fibrin(ogen). cFXIII does not require proteolysis for intracellular activation. The three-dimensional structure of FXIIIa has not been resolved. Based on analogies with transglutaminase-2, a three-dimensional structure of FXIIIa was developed by molecular modeling, which shows good agreement with the drastic structural changes demonstrated by biochemical studies. The structural requirements for enzyme-substrate interaction and for transglutaminase activity are also reviewed.
因子(F)XIII 是一种前转谷氨酰胺酶,除了维持止血作用外,还具有多种血浆和细胞内功能。其血浆形式(pFXIII)是由两个潜在活性 A(FXIII-A)和两个抑制/载体 B(FXIII-B)亚基组成的四聚体,而其细胞形式(cFXIII)是 FXIII-A 的二聚体。FXIII-A 属于转谷氨酰胺酶(TGs)家族,它们在一级结构上具有一定的相似性,但在结构域和亚结构域的二级结构上具有高度的保守性。FXIII-A 由激活肽、β-三明治、催化和两个β-桶结构域组成。FXIII-B 是一种糖蛋白,由 10 个重复的 sushi 结构域组成,每个 sushi 结构域由两个内部二硫键连接。FXIII-A 中与 FXIII-B 相互作用的结构元素尚未阐明;在 FXIII-B 中,第一个 sushi 结构域似乎对复合物形成很重要。在循环中,pFXIII 通过其 B 亚基与纤维蛋白原γ'-链结合。在 pFXIII 激活过程中,首先凝血酶从 FXIII-A 上切下激活肽,然后在 Ca(2+)存在下,FXIII-B 解离,FXIII-A 转化为活性转谷氨酰胺酶(FXIIIa)。纤维蛋白(原)的存在极大地加速了激活过程。cFXIII 不需要蛋白水解即可在细胞内激活。FXIIIa 的三维结构尚未解析。基于与转谷氨酰胺酶-2 的类比,通过分子建模构建了 FXIIIa 的三维结构,该结构与生化研究表明的剧烈结构变化非常吻合。还综述了酶-底物相互作用和转谷氨酰胺酶活性的结构要求。